Veterinary Medicines

Ovilis Heptavac P Plus BG

Authorised
  • Bibersteinia trehalosi, Inactivated
  • Mannheimia haemolytica, Inactivated
  • Clostridium chauvoei, Inactivated
  • Clostridium novyi, toxoid
  • CLOSTRIDIUM TETANI
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, beta toxoid
Download as PDF

Product identification

Medicine name:
Ovilis Heptavac P Plus BG
Active substance:
  • Bibersteinia trehalosi, Inactivated
  • Mannheimia haemolytica, Inactivated
  • Clostridium chauvoei, Inactivated
  • Clostridium novyi, toxoid
  • CLOSTRIDIUM TETANI
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, beta toxoid
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bibersteinia trehalosi, Inactivated
    5.00
    million cells
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, Inactivated
    5.00
    million cells
    /
    1.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    1.25
    million cells
    /
    1.00
    millilitre(s)
  • Clostridium novyi, toxoid
    8.00
    unit(s)
    /
    1.00
    millilitre(s)
  • CLOSTRIDIUM TETANI
    6.00
    unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    3.00
    unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    80.00
    unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type C, beta toxoid
    30.00
    unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, beta toxoid
    10.00
    unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1891
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 21/10/2024
Updated on: 20/10/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 21/10/2024
Updated on: 20/10/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 21/10/2024
Updated on: 20/10/2024
Download